


Pfizer and Moderna are projecting a combined $51 billion in sales this year from their COVID-19 vaccines as the companies are criticized for their ‘greed’ in the vaccine rollout.
Pfizer and Moderna are projecting a combined $51 billion in sales this year from their COVID-19 vaccines as the companies are criticized for their ‘greed’ in the vaccine rollout.